Logo

Agena Bioscience Opens Shanghai Office

Sep 01, 2015 | staff reporter

NEW YORK (GenomeWeb) – San Diego-based Agena Bioscience today announced it has established a subsidiary in Shanghai.

"The Chinese market represents a significant portion of Agena Bioscience's global sales with almost 60 MassArray Systems installed to date," Agena CEO Pete Dansky said in a statement. "Direct presence within China will allow us to expand our reach and foster a high degree of engagement with our local customers in that region."

The firm has hired Bob Wang, a former Qiagen marketing director, to lead the Chinese subsidiary.

In June, Agena added distributors for the MassArray system in Poland and Russia.

Filed under

Molecular Diagnostics
Business News
PCR
Breaking News
The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.